APA (7th ed.) Citation

Y, F., N, Y., Y, Y., K, Y., T, O., S, K., . . . T, T. (2009). Phase I and pharmacokinetic study of vorinostat (suberoylanilide hydroxamic acid) in Japanese patients with solid tumors. Cancer science, 100(9), 1728. https://doi.org/10.1111/j.1349-7006.2009.01237.x

Chicago Style (17th ed.) Citation

Y, Fujiwara, Yamamoto N, Yamada Y, Yamada K, Otsuki T, Kanazu S, Iwasa T, Hardwick JS, and Tamura T. "Phase I and Pharmacokinetic Study of Vorinostat (suberoylanilide Hydroxamic Acid) in Japanese Patients with Solid Tumors." Cancer Science 100, no. 9 (2009): 1728. https://doi.org/10.1111/j.1349-7006.2009.01237.x.

MLA (9th ed.) Citation

Y, Fujiwara, et al. "Phase I and Pharmacokinetic Study of Vorinostat (suberoylanilide Hydroxamic Acid) in Japanese Patients with Solid Tumors." Cancer Science, vol. 100, no. 9, 2009, p. 1728, https://doi.org/10.1111/j.1349-7006.2009.01237.x.